Diabetes drug linked to osteoporosis
GSK’s drug for diabetes Avandia (Rosiglitazone) has come under the scanner after reports that the drug increases the risk of Osteoporosis has been confirmed.
Rosiglitazone belongs to a class of drugs called as Thiazolidinediones (aka PPAR Gamma activators) and the other drug in this class is Pioglitazone. It has been a useful drug in the management of Type II Diabetes and it works by increasing the sensitivity of the body cells to circulating Insulin.
Post Reactions